Last viewed:
RLAY
Prices are updated after-hours
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
(0.0% 1d)
(-22.3% 1m)
(-50.2% 1y)
(0.0% 2d)
(0.0% 3d)
(-9.1% 7d)
(60.67%
volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 781,827,043
http://www.relaytx.com
Sec
Filling
|
Patents
| 122 employees
(US) Relay Therapeutics, Inc. is a clinical-stage precision medicines company. It focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
computational
add to watch list
Paper trade
email alert is off
Press-releases
Relay Therapeutics to Participate in Upcoming Investor Conferences
Published: 2024-04-11
(Crawled : 20:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -12.9%
| O: 0.56%
H: 0.14%
C: -1.95%
relay
therapeutics
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
Published: 2024-02-26
(Crawled : 21:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -38.88%
| O: 1.48%
H: 3.49%
C: -0.19%
relay
therapeutics
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
Published: 2024-02-22
(Crawled : 21:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -41.25%
| O: 2.46%
H: 0.55%
C: -7.66%
year
relay
therapeutics
financial
results
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
Published: 2024-02-15
(Crawled : 21:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -41.8%
| O: -1.22%
H: 5.88%
C: 2.85%
year
relay
therapeutics
financial
results
Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Published: 2024-02-01
(Crawled : 21:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -31.83%
| O: 0.33%
H: 3.28%
C: -1.53%
conference
relay
therapeutics
Relay Therapeutics Announces $30 Million Private Placement Financing
Published: 2024-01-08
(Crawled : 12:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -46.0%
| O: 4.09%
H: 1.42%
C: 0.84%
million
relay
therapeutics
Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-02
(Crawled : 21:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -47.62%
| O: -0.13%
H: 0.04%
C: -2.53%
conference
relay
therapeutics
Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference
Published: 2023-11-07
(Crawled : 21:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -23.8%
| O: 0.61%
H: 0.0%
C: -4.39%
conference
relay
therapeutics
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
Published: 2023-11-02
(Crawled : 20:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -16.08%
| O: 12.97%
H: 0.72%
C: -10.05%
relay
therapeutics
financial
results
Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023
Published: 2023-10-26
(Crawled : 21:00)
- globenewswire.com
RLAY
|
$5.96
-2.46%
-2.52%
2.4M
|
Health Technology
| -1.9%
| O: 0.47%
H: 0.63%
C: -4.72%
relay
therapeutics
financial
results
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001209191-24-001847
4
2024-01-18
2024-01-16
Buy
A
200000
516628